NJ State Employees Deferred Compensation Plan’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-38,000
Closed -$40K 575
2019
Q1
$40K Hold
38,000
0.01% 534
2018
Q4
$28K Hold
38,000
0.01% 512
2018
Q3
$81K Hold
38,000
0.01% 506
2018
Q2
$88K Hold
38,000
0.02% 493
2018
Q1
$121K Hold
38,000
0.02% 462
2017
Q4
$156K Hold
38,000
0.03% 451
2017
Q3
$172K Sell
38,000
-10,000
-21% -$40.5K 0.03% 439
2017
Q2
$160K Hold
48,000
0.03% 396
2017
Q1
$442K Sell
48,000
-22,000
-31% -$193K 0.08% 284
2016
Q4
$540K Hold
70,000
0.11% 263
2016
Q3
$800K Hold
70,000
0.17% 204
2016
Q2
$862K Hold
70,000
0.18% 194
2016
Q1
$784K Hold
70,000
0.17% 206
2015
Q4
$1.58M Buy
+70,000
New +$1.43M 0.32% 90

NJ State Employees Deferred Compensation Plan's OMED Position: Q2 2019 in Review

NJ State Employees Deferred Compensation Plan sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q2 2019, closing a stake of 38,000 shares — an estimated $40K sold.

NJ State Employees Deferred Compensation Plan first reported a position in OMED in Q4 2015 and held it in 14 quarters. The position peaked at $1.58M in Q4 2015. 0 funds tracked by Wall St. Rank hold OMED as of Q2 2019.

  • NJ State Employees Deferred Compensation Plan reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
  • NJ State Employees Deferred Compensation Plan sold 38,000 OncoMed Pharmaceuticals, Inc. shares in Q2 2019, an estimated $40K.
  • NJ State Employees Deferred Compensation Plan first reported a position in OncoMed Pharmaceuticals, Inc. in Q4 2015 and held it in 14 quarters.
  • NJ State Employees Deferred Compensation Plan's OncoMed Pharmaceuticals, Inc. position peaked at $1.58M in Q4 2015.
  • 0 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q2 2019.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q2 2019, filed 24 Jul 2019.